Equity Capital Markets

Pacira BioSciences, Inc.

05/24
|
$250.0 Million
Pacira BioSciences, Inc.
Piper Sandler served as bookrunner for Pacira BioSciences, Inc. on its convertible senior note offering
Sub-Type
Convertible Offering
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
Service Titan
ServiceTitan, Inc.
Initial Public Offering
Passive Bookrunner
Financial Institutions, Inc.
Financial Institutions, Inc.
Confidentially Marketed Follow-On Offering
Co-Manager
Solaris Energy Infrastructure, Inc.
Solaris Energy Infrastructure, Inc.
Follow-On Offering
Passive Bookrunner
$100.0 Million
Immunity
ImmunityBio
Confidentially Marketed Follow-on Offering
Active Bookrunner
$8.5 Billion
Arthur J. Gallagher & Co.
Arthur J. Gallagher & Co.
Follow-On Offering
Co-Manager
$661.2 Million
semtech
Semtech Corporation
Follow-On Offering
Co-Manager
$91.9 Million
Equity Bancshares, Inc.
Equity Bancshares, Inc.
Confidentially Marketed Follow-On Offering
Co-Manager
$100.0 Million
Abacus Life
Abacus Life, Inc
Follow-On Offering
Active Bookrunner
$230.0 Million
Farmers
Merchants Bancorp
7.625% Fixed Rates Series E Non-Cumulative Perpetual Preferred Stock
Active Bookrunner
One Stream
OneStream Software
Follow-On Offering
Passive Bookrunner
$80.6 Million
Mid Penn Bancorp, Inc.
Mid Penn Bancorp, Inc.
Common Stock Offering
Active Bookrunner
$175.0 Million
Procept Biorobotics Corp.
Procept Biorobotics Corp.
Follow-On Offering
Active Bookrunner
$60.1 Million
enGene, Inc.
enGene, Inc.
PIPE
Joint Placement Agent
Marex Group plc
Marex Group plc
Follow-On Offering
Passive Bookrunner
$75.0 Million
capricor
Capricor Therapeutics, Inc.
Follow-on offering
Left Bookrunner
$297.5 Million
Upstreambio
Upstream Bio, Inc.
Initial Public Offering
Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.